|
FOR IMMEDIATE RELEASE Contact: James Heins Purdue Appoints Watson Pharmaceuticals Exclusive Distributor of Authorized Generic Versions of OxyContin® Tablets Stamford, CT - October 28, 2005 - Purdue Pharma L.P. today announced that it has appointed Watson Pharmaceuticals the exclusive U.S. distributor of authorized generic versions of OxyContin® (oxycodone HCl controlled-release) Tablets. Purdue has exercised it right to terminate a previous agreement with IVAX Pharmaceuticals to distribute the authorized generic product. Purdue will continue to manufacture and market its branded OxyContin product line. Under the terms of the new agreement, Purdue will manufacture and supply oxycodone HCl controlled-release tablets to Watson, which will market, sell, and distribute the authorized generic product in 10, 20, 40 and 80 milligram dosages in the United States. This product will continue to meet all quality control standards of the OxyContin brand and will contain the same active and inactive pharmaceutical ingredients. The professional product labeling for OxyContin® Tablets contains the following boxed warning:
Full prescribing information for OxyContin is available at # # # |